Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure (COV-IMMUNO)
COV-IMMUNO: A Randomized, Phase III Trial of Immunization With IMM-101 Versus Observation for the Prevention of Severe Respiratory and COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure
Sponsor: ATGen Canada Inc
Listed as NCT04442048, this PHASE3 trial focuses on Cancer and Covid-19 and remains completed. Sponsored by ATGen Canada Inc, it has been updated 24 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
24 versions recorded-
Jan 2026 — Present [monthly]
Completed PHASE3
Status: Active Not Recruiting → Completed
-
Sep 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE3
-
May 2025 — Sep 2025 [monthly]
Active Not Recruiting PHASE3
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE3
▶ Show 19 earlier versions
-
Jul 2024 — Aug 2024 [monthly]
Active Not Recruiting PHASE3
-
Dec 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE3
-
Sep 2023 — Dec 2023 [monthly]
Active Not Recruiting PHASE3
-
Aug 2023 — Sep 2023 [monthly]
Active Not Recruiting PHASE3
-
Feb 2023 — Aug 2023 [monthly]
Active Not Recruiting PHASE3
-
Sep 2022 — Feb 2023 [monthly]
Active Not Recruiting PHASE3
-
Jul 2022 — Sep 2022 [monthly]
Active Not Recruiting PHASE3
-
May 2022 — Jul 2022 [monthly]
Active Not Recruiting PHASE3
-
Jun 2021 — May 2022 [monthly]
Active Not Recruiting PHASE3
Status: Recruiting → Active Not Recruiting
-
May 2021 — Jun 2021 [monthly]
Recruiting PHASE3
-
Apr 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Feb 2021 — Apr 2021 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Nov 2020 — Dec 2020 [monthly]
Recruiting PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE3
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE3
-
Jul 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- ATGen Canada Inc
- BioCan Rx
- Canadian Cancer Society (CCS)
- Canadian Cancer Trials Group
- Canadian Centre for Applied Research in Cancer Control (ARCC)
- Immodulon Therapeutics Ltd
- Ontario Institute for Cancer Research
For direct contact, visit the study record on ClinicalTrials.gov .